RSU grant lifts AngioDynamics Inc. (ANGO) director to 116,921 shares

Rhea-AI Filing Summary

REED JAN STERN reported acquisition or exercise transactions in this Form 4 filing.

AngioDynamics Inc. director Jan Stern Reed received a grant of 11,887 shares of common stock on July 15, 2026, reported at a price of $0.00 per share. A footnote explains this represents 11,887 restricted stock units granted as regular annual compensation for board service that immediately vested at grant. Following this award, Reed directly holds 116,921 common shares.

Insider Trade Summary

Net Buyer: 11,887 shares

Net Buy 1 txn

Insider REED JAN STERN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	11,887	$0.00	$0.00

Holdings After Transaction: Common Stock — 116,921 shares (Direct)

Footnotes (1)

1. F1. The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.

Key Figures

Shares granted: 11,887 shares Shares held after transaction: 116,921 shares Reported grant price: $0.00 per share

3 metrics

Shares granted 11,887 shares Restricted stock units granted July 15, 2026 as regular annual director compensation

Shares held after transaction 116,921 shares Direct AngioDynamics common stock ownership following the award

Reported grant price $0.00 per share Transaction price per share for the stock award

Key Terms

restricted stock units, regular annual compensation, immediately vested

3 terms

restricted stock units financial

"represents 11,887 restricted stock units granted as regular annual compensation"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

regular annual compensation financial

"restricted stock units granted as regular annual compensation for service as a director"

immediately vested financial

"The restricted stock units immediately vested at the time of grant."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/22/2026 - 08:06 PM Accepted by SEC EDGAR 07/22/2026 - 08:06 PM Learn about SEC filing dates

FAQ

What insider transaction did AngioDynamics (ANGO) report for Jan Stern Reed?

Jan Stern Reed received 11,887 shares of common stock on July 15, 2026, as a stock-based award. A footnote states this reflects 11,887 restricted stock units granted as regular annual director compensation that immediately vested into common shares.

How many AngioDynamics (ANGO) shares does Jan Stern Reed hold after this Form 4?

After the July 15, 2026 award, Jan Stern Reed directly holds 116,921 AngioDynamics common shares. This total includes the 11,887 restricted stock units that were granted as annual director compensation and immediately vested at the time of grant.

Was the AngioDynamics (ANGO) Form 4 transaction a purchase or a grant?

The Form 4 reports an award of shares, not an open-market purchase. It reflects 11,887 restricted stock units granted as regular annual compensation for serving as a director, which vested immediately into common stock at a reported price of $0.00 per share.

What type of equity did AngioDynamics (ANGO) grant to Jan Stern Reed?

AngioDynamics granted 11,887 restricted stock units (RSUs) to Jan Stern Reed. According to the footnote, these RSUs were issued as regular annual director compensation and immediately vested at the time of grant, resulting in common stock ownership.

Did Jan Stern Reed pay cash for the AngioDynamics (ANGO) shares reported?

No cash payment is reported; the transaction price is $0.00 per share. The shares came from a grant of restricted stock units provided as regular annual compensation for board service, which immediately vested rather than being bought on the open market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REED JAN STERN

(Last) (First) (Middle)

14 PLAZA DRIVE

(Street)

LATHAM NEW YORK 12110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		A		11,887(1)	A	$0	116,921	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.

	/s/ Lawrence T. Weiss, Attorney in Fact	07/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)